Health technology assessment in the Irish healthcare setting : application to oral anticoagulants
Citation:Laura M. McCullagh, 'Health technology assessment in the Irish healthcare setting : application to oral anticoagulants', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Pharmacology & Therapeutics, 2012, pp 316
McCullagh TCD THESIS 9704 Health technology.pdf (PDF) 197.5Mb
The objective of this thesis was to examine the application of economic evaluation within the Irish healthcare setting. In so doing, the author sought to develop skills in indirect comparison, economic modelling, value of information analysis and prescribing database analysis. The therapeutic area chosen was the new oral anticoagulants. Rivaroxaban (Xarelto®) and dabigatran (Pradaxa®) were licensed in Ireland in 2008 for the primary prevention of venous thromboembolism (VTE) in adults undergoing elective total hip replacement (THR) and total knee replacement (TKR).
Author: McCullagh, Laura M.
Publisher:Trinity College (Dublin, Ireland). School of Medicine. Discipline of Pharmacology & Therapeutics
Note:TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: firstname.lastname@example.org
Type of material:thesis
Availability:Full text available